can aggravate the degeneration of the overlying cartilage and an improved subchondral bone can retard cartilage degeneration, [5] [6] [7] [8] [9] [10] which indicates that the properties of subchondral bone influence the integrity of articular cartilage in the pathogenesis of OA. From the biomechanical point of view, articular cartilage contains a lot of water and has a strong capacity to withstand compressive stress but has weak capacities to withstand tensile and shear stress. Heterogeneities in the density and rigidity of subchondral bone in OA, along with mutated material composition and disorganized microstructure, result in abnormal tensile stress and shear stress toward articular cartilage, thus facilitating cartilage degeneration. However, the characteristics of subchondral bone alterations remain unresolved, and a better understanding of these alterations may contribute to the development of bone-targeting therapies.
Clinical data have demonstrated that osteoarthritic subchondral bone turnover increases dramatically, [6, 11] which results in disorganized bone architecture, decreased mineralization, and weakened biomechanical properties. [12] [13] [14] Subchondral osteoblasts and osteoclasts manifest abnormal functions, [15, 16] producing various cytokines, growth factors, prostaglandins, and leukotrienes, which could accelerate cartilage degradation. [17] However, most of these studies were focused on end-stage disease, which reveals little about early deregulation of bone turnover.
Many animal models have been developed to study the pathophysiology of OA and to evaluate potential therapeutics. [18, 19] Alterations in the subchondral bone have been detected with dual-energy X-ray absorptiometry, [20, 21] histomorphometry, [21] [22] [23] [24] or micro-computed tomography (micro-CT). [9, 25, 26] These changes include increased bone resorption in the early stage of OA, indicated as reduced bone mineral density (BMD), bone volume, trabecular thickness (Tb.Th) and connectivity, and increased bone accretion later in the disease, with increases in bone volume and Tb.Th, decreases in trabecular number (Tb.N) and separation, and subchondral sclerosis.
However, bone is a complex tissue, the principal function of which is to resist mechanical forces, with its overall properties depending not only on quantity but also on quality, as characterized by its architecture, material composition (mineral and collagen), and intrinsic mechanical properties. [27, 28] Presently, there is no report on the alterations in the overall properties of subchondral bone during OA progression. Confocal Raman spectroscopy systems, which are capable of probing the physiochemical properties of bone tissue based on the ratios of relative Raman peak intensity generated by the mineral and collagen phases, [29] has been used to evaluate the mineral-to-collagen ratio of bone in recent years. Nanoindentation, which emerged as a powerful tool for measuring the mechanical properties of small and complex biomaterials, has been used to investigate variations in the mechanical properties of trabecular and cortical bone in osteoporosis. [30, 31] Thus, using histology, micro-CT, Raman spectroscopy and nanoindentation, the current study observed the potential changes in the microarchitecture, tissue mineral density (TMD), mineral-to-collagen ratio, and intrinsic mechanical properties to evaluate the properties of subchondral bone in the commonly used rat medial meniscal tear (MMT) model of OA.
Methods

Animals
Adult male Sprague Dawley rats (12 weeks old, weighing 276 ± 16 g) from Sino-British Sippr/BK Lab Animal Ltd., (Shanghai, China) were used in the present study. The animals were group housed under a 12-h light/dark cycle with food and water provided ad libitum. The animals received standard laboratory chow containing 1.56% calcium, 0.8% phosphorus, and 800 IU/kg Vitamin D. The Animal Care and Experiment Committee of Shanghai Jiao Tong University School of Medicine approved all experimental procedures.
Induction of osteoarthritis and experimental design
The rats were anesthetized with 10% chloral hydrate in phosphate-buffered saline (0.01 mol/L) after 1 week of acclimatization. The MMT model was induced as previously described. [32] Briefly, the medial collateral ligament of the right knee was transected, and the medial meniscus was reflected proximally toward the femur and cut through at its narrowest point. For the controls (Sham), the wounds were closed after exposing the medial collateral ligament. A total of 128 animals (64 for MMT and Sham groups, respectively) were used to observe changes in cartilage and subchondral bone. Animals were sacrificed at 2, 4, 8, and 12 weeks after the operation.
Tissue preparation
The entire knee joint was dissected and fixed in 4% paraformaldehyde for 48 h. Eight joints from each group at every time point were decalcified in 10% ethylenediaminetetraacetic acid for 3 weeks. The joints were then bisected along the collateral ligament in the frontal plane, and both sections were embedded in the same paraffin block. The samples were cut into 5-μm sections and prepared for toluidine blue O staining to evaluate cartilage degeneration. The other 8 undecalcified joints from the Sham and MMT groups at each time point were used to evaluate the properties of subchondral bone, including micro-CT imaging, confocal Raman microspectroscopy, and nanoindentation.
Histological analysis
On the basis of the Osteoarthritis Research Society International (OARSI) recommendations for the histological assessment of OA in the rat, [33] 3 sections from each knee at 200-mm steps were stained with toluidine blue O and subsequently evaluated for cartilage degeneration. For toluidine blue O staining, the sections were stained with 0.04% w/v toluidine blue O (Sigma, T0394, USA) in 0.1 mol/L sodium acetate (pH 4.0) for 10 min, rinsed briefly, air-dried and mounted. The medial tibial plateau was divided into three regions of equal width, and cartilage degeneration in each zone was scored "none" to "severe" (numerical values 0-5) using the criteria described in Table 1 . The original surface of the tissue was estimated. Then, the percentage area of each zone containing cartilage exhibiting loss of chondrocytes or loss of matrix was estimated, and a score was assigned to that zone based on that percentage. The total cartilage degeneration score was calculated by adding the values obtained for each zone.
Micro-computed tomography imaging and analysis
Structural alterations and the tissue mineral content in the subchondral bone were evaluated using micro-CT. The knee joints were scanned by micro-CT (μCT 80; Scanco Medical AG, Bassersdorf, Switzerland) with an isotropic voxel resolution of 10 μm. As shown in our previous study, [34] a portion (2.0 mm ventrodorsal length) of the load-bearing region at the medial tibial plateau was identified as a region of interest [ Figure 1 ]. Both subchondral bone plate (BP) and trabecular bone (Tb) parameters were calculated.
Confocal Raman microspectroscopy
The chemical composition of the subchondral bone tissue (mineral-to-collagen ratio, υ 1 -PO 4 
3−
/proline) was characterized by confocal Raman microspectroscopy (Renishaw Inc., Hoffman Estates, IL, USA) as described previously. [8, 35] After micro-CT scanning, joint samples were dehydrated in a graded alcohol series, embedded in methyl methacrylate (MMA) and sliced in the frontal plane using a Leica SP1600 saw microtome. The section surface was ground on successive grits of wet silicon carbide paper and polished by hand with 1 μm alumina slurry, and 3 sections of 30 μm thickness from each sample were obtained and analyzed. A 50X objective focused the laser (785 nm laser diode source) on a 3 μm region within the medial tibial plateau, and Raman scattered light was collected by a spectrograph with 0.5 cm −1 spectral resolution. The measured spectra consisted of three accumulations with an integration time of 10 s each. Using custom-developed software (MATLAB, MathWorks, Natick, MA, USA), the background fluorescence in the spectra was subtracted by a modified polynomial fitting algorithm. [36] Underlying the regions of articular cartilage damage, spectra were collected from three locations within the subchondral BP and eight locations within the Tb. The υ 1 -PO 4 3− / proline ratio was then calculated as the raw υ 1 phosphate peak intensity (υ 1 ) and averaged per section.
Nanoindentation testing
The mechanical properties at the tissue level were quantified by nanoindentation as described previously. [37] Following the confocal Raman microspectroscopy, the medial tibial plateau of MMA-embedded knee sections were probed using a TriboIndenter (Hysitron Inc., Minneapolis, MN, USA). A Berkovitch diamond tip (inclination angle 142.35°, radius 200 nm) was pressed into the surface using a trapezoidal loading scheme as follows: (1) Loading up to a nominal load of 1000 μN at a rate of 200 μN/s; (2) holding at Pmax for 5 s; and (3) unloading to zero load at a rate of 200 μN/s. Thermal drift was corrected in the measurement software (Triboscan) by measuring the indenter drift for a maximum of 40 s before the start of every indent and applying this correction to the measured data. From the resulting force-displacement curve, the elastic modulus (E r ) and hardness (H) of the tissue at the point of indention (0.25 μm resolution) was calculated following the method of Oliver and Pharr. [38] Underlying the regions of articular cartilage damage, three locations on BP and eight locations on Tb per section were chosen, and four indents for each location were tested and averaged per section.
Statistical analysis
All of the statistical analyses were performed by blinded authors who were unaware of the treatments given. The results were presented as the mean ± standard deviation (SD). A comparison between the Sham and MMT groups was performed with an independent-samples t-test. P < 0.05 was considered statistically significant. Statistical analysis was conducted with SPSS for Windows, version 11.5 (SPSS Inc., Chicago, IL, USA).
Results
Articular cartilage degeneration
As indicated by toluidine blue O staining [ Figure 2 ], MMT induced cartilage degeneration primarily on the outer regions of the medial tibia platform. Cartilage matrix and chondrocyte loss occurred and worsened in a time-dependent manner from 2 to 12 weeks postsurgery, whereas the Sham joints showed no obvious changes at any time point. At 2 weeks, matrix and chondrocyte loss mainly affected the superficial and upper middle zone. Subsequently, these changes reached the deep zone and extended more substantially into the medial tibial plateau at 4 weeks. Severe degeneration occurred at 8 weeks with full thickness involvement into the tidemark, which became more widespread at 12 weeks. Specifically, the cartilage degeneration scores for the MMT joints were 3.60 ± 0.52, 6.33 ± 0.74, 9.18 ± 1.13, and 12.85 ± 1.36 at 2, 4, 8, and 12 weeks, respectively.
Changes in subchondral bone microarchitecture and tissue mineral density
Representative pictures of the knee joints from Sham and MMT groups obtained by micro-CT scanning are shown in Figure 3 . In general, subchondral bone of the medial tibial plateau showed dynamic alterations following OA induction from bone resorption at the early stages (2 and 4 weeks) to bone accretion at the advanced stages (8 and 12 weeks). Specifically, compared with the Sham groups, the thickness of subchondral bone plate (BP.Th) in the MMT groups showed no significant changes at 2 and 4 weeks (P > 0.05, respectively), but increased significantly at 8 and 12 weeks (P < 0.05 and P < 0.01, respectively). The bone volume fraction (BV/TV) of Tb decreased at 2 and 4 weeks (P < 0.01, respectively) and increased at 8 and 12 weeks (P < 0.05, respectively). These changes were accompanied by the Tb.Th changing from thinner (2 and 4 weeks, P < 0.05, respectively) to thicker (8 and 12 weeks, P < 0.01, respectively), the trabecular spacing (Tb.Sp) from broader (2 and 4 weeks, P < 0.05 and P < 0.01, respectively) to narrower (8 and 12 weeks, P < 0.05 and P < 0.01, respectively), and the Tb.N and connectivity density (Cnn.D) being reduced at all times (P < 0.01). With respect to TMD, compared with the Sham groups, both the subchondral BP and Tb displayed no significant changes at 2 and 4 weeks (P > 0.05, respectively), but decreased at 8 and 12 weeks (P < 0.05, respectively).
Changes in subchondral bone mineral-to-collagen ratio
The mineral-to-collagen ratio of the subchondral bone tissue, calculated as the υ 1 -PO 4 3 − peak intensity per proline peak intensity (PO4 3− /proline) using confocal Raman microspectroscopy, is shown in Figure 4 . In general, no significant difference in mineral-to-collagen ratio was observed among the Sham groups, whereas, a reduced mineral-to-collagen ratio was found in MMT animals that were aggravated with the progression of the disease. Specifically, the mineral-to-collagen ratio of the subchondral BP in MMT animals was reduced from 10.14 ± 1.94 at 2 weeks to 8.21 ± 1.45 at 12 weeks. Simultaneously, the mineral-to-collagen ratio of the Tb in MMT animals was reduced from 9.09 ± 1.97 at 2 weeks to 6.66 ± 1.43 at 12 weeks.
Changes in intrinsic bone mechanical properties
The intrinsic bone tissue mechanical properties, displayed as elastic modulus E r and hardness H quantified by nanoindentation, are shown in Figures 5 and 6 . The mechanical properties of the subchondral bone in the Sham groups showed no significant changes throughout the course of the experiment, whereas the mechanical properties of subchondral bone in the MMT groups were gradually reduced as the disease progressed following the MMT operation. Specifically, the elastic modulus of the subchondral BP in MMT animals was reduced from 21.75 ± 3.64 GPa at 2 weeks to 17.41 ± 3.88 GPa at 12 weeks, whereas the hardness was reduced from 0.96 ± 0.13 GPa at 2 weeks to 0.76 ± 0.13 GPa at 12 weeks. With respect to the Tb, the elastic modulus in MMT animals was reduced from 19.62 ± 3.64 GPa at 2 weeks to 14.08 ± 3.88 GPa at 12 weeks, whereas the hardness was reduced from 0.88 ± 0.11 GPa at 2 weeks to 0.68 ± 0.12 GPa at 12 weeks.
dIscussIon
The rat MMT model is well-established and commonly used to study the pathophysiology of OA and to evaluate potential therapeutics. [19, 33] Consistent with previous results, [33] the present study demonstrated that cartilage degeneration and subchondral alterations occurred in a time-dependent manner in the rat MMT model. Bone resorption dominates the early stage of disease, manifested as a decreased BV/TV ratio, reduced Tb.N and Cnn.D, thinned Tb.Th, and broadened Tb.Sp. With the progression of the disease, bone alterations shift from bone resorption to a bone formation at an advanced stage, manifested as increased BV/TV ratio, thickened Tb.Th and narrowed Tb.Sp.
Bone is a complex tissue, its overall properties depending not only on quantity, as manifested by BMD and BV/TV, but also on quality, as embodied in TMD, architecture, material composition, and mechanical properties. [27, 28] For the first time, the present study observed the changes in the material composition and mechanical properties of subchondral bone in a rat MMT model of OA. Our data revealed that both the subchondral BP and Tb demonstrated a gradually reduced mineral-to-collagen ratio, elastic modulus and hardness with the progression of the disease. Consistent with our findings, a subchondral bone from patients with late OA showed decreased mineralization. [12, 39] The potential mechanism by which mineralization and mechanical properties were reduced may lie in the increased bone turnover of the osteoarthritic subchondral bone. [13, 40] Bone turnover, which is mediated by osteoclast-osteoblast coupling as the main biological determinant of bone mineralization, increases dramatically in the pathogenesis of OA. [41] This accounts for much of the bone that lacked an opportunity to fully mineralize, resulting in the corresponding reduction of mechanical properties. Due to reduced intrinsic mechanical properties, subchondral osteoblast enhanced anabolic activity, and increased bone formation [15] to bear abnormal joint stress, [42] which led to an increased BV/TV ratio, thickened BP and Tb.Th, and narrowed Tb.Sp. Consequently, incomplete mineralization, reduced intrinsic mechanical properties, increased bone formation and abnormal joint stress contribute together to flattening, depression and sclerosis of the articular surface, which can be observed on radiographs or magnetic resonance imaging.
Subchondral bone consists of the corticalized BP and the underlying Tb. [43] Inconsistent results with respect to the BP.Th in OA were obtained in previous studies. Samples from patients with late OA displayed thickened subchondral BPs. [13] In animal experiments, some observed a thinned subchondral BP, [44] [45] [46] whereas others observed a thickened subchondral BP. [24, 47, 48] The current study demonstrated that the BP.Th showed no obvious difference at the early stage but found thickening at the late stage in the rat MMT model. The inconsistency may be attributed to the adoption of different animal models or measurements and/or differences in the time points or stages of disease progression observed. The subchondral BP and Tb showed similar trends in TMD, the mineral-to-collagen ratio and mechanical properties with the progression of disease in the present MMT model. Compared with the BP, the Tb changed earlier and more obviously, similar to the phenomenon in osteoporosis when Tb shows more obvious changes than cortical bone owing to the high bone turnover rate in Tb. [49] The precise causes leading to dynamic alterations in subchondral bone with disease progression remain unknown. The possible mechanisms of increased subchondral bone remodeling in early OA may include repair of microscopic damage, [50, 51] vascular invasion induced by pro-angiogenic factors, [52] and bone and cartilage interactions through micropores [53] in the subchondral bone. While the mechanisms, by which subchondral bone mineralization is reduced in late OA may be related to osteoblast differentiation factors. [54] It has been shown that interaction between bone and cartilage is strengthened in OA, [46, 53] and the subchondral osteoblasts, osteoclasts in OA can release a variety of proteases, inflammatory mediators, and growth factors that can promote chondrocyte death in the upper layer and matrix degradation. [17] However, the present study only observed subchondral changes in the biomechanical point of view. Further study of subchondral bone is needed from the aspect of molecular biology. Finally, the present findings may have some implications for the treatment of OA with bone-modifying agents. Previous preclinical studies have revealed that targeting subchondral bone with bone-modifying agents, [8, 23, 55, 56] such as the anti-bone resorption drugs of estrogen, calcitonin, bisphosphonates and OPG, the pro-osteogenesis drug teriparatide, and the bidirectional regulation drug strontium ranelate, has protective effects on osteoarthritic articular cartilage, and a number of clinical trial results also support the positive roles of osteoprotective agents in inhibiting the degradation of cartilage type II collagen and delaying cartilage degeneration in OA. [57] [58] [59] However, these protective effects have not been consistently confirmed by clinical data. [41, 60] The present findings that the properties of subchondral bone are dynamic with disease progression indicate that abnormal subchondral bone cannot always be modified, and the stage of disease progression may influence the efficacy of bone-modifying therapy.
In conclusion, alterations in the bone volume, microarchitecture, TMD, mineral-to-collagen ratio, and intrinsic mechanical properties of subchondral bone change in a time-dependent manner as the disease progresses in the rat MMT model of OA. 
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